ZYME: the balance sheet

MyFinsight

For the year ending 2025-12-31, ZYME has $346,527K in assets. $78,026K in debts. $41,157K in cash and cash equivalents.

Balance Sheets	2025-12-31
Cash and cash equivalents	41,157
Short-term marketable securities (note 5)	187,640
Accounts receivable	4,638
Prepaid expenses and other current assets	15,332
Total current assets	248,767
Long-term marketable securities (note 5)	41,787
Long-term prepaids and other assets	6,674
Deferred tax asset(note 13)	4,707
Property and equipment, net (note 7)	15,502
Operating lease right-of-use assets (note 14)	15,724
Intangible assets, net (note 8)	1,350
Goodwill (note 6)	12,016
Total assets	346,527

Accounts payable and accrued liabilities (note 9)	36,346
Income tax payable (note 13)	83
Current portion of operating lease liability (note 14)	3,471
Deferred revenue and other consideration (note 11)	2,418
Total current liabilities	42,318
Long-term portion of operating lease liability (note 14)	14,796
Deferred revenue (note 11)	14,606
Other long-term liabilities(note 9)	278
Deferred tax liability (note 13)	6,028
Total liabilities	78,026
Common shares, 0.00001 par value 900,000,000 authorized shares of common stock at december31, 2025 and december31, 2024 (74,638,413 and 68,964,319 shares issued and outstanding at december31, 2025 and 2024, respectively (note 10b)	1,105,176
Exchangeable shares, no par value, 553,184 issued and outstanding shares at december31, 2025 (december31, 2024 570,637) (note 10b)	7,938
Additional paid-in capital	114,626
Accumulated other comprehensive loss	-6,079
Accumulated deficit	-953,160
Total stockholders equity	268,501
Total liabilities and stockholdersequity	346,527

Unit: Thousand (K) dollars (except for numbers of shares and EPS).